As a global pharmaceutical company with a biotech mindset and a proven ability to provide new, life-changing therapies, Ipsen is a leading player in its core therapeutic areas.

2017 registration document

Download now

Financial calender

Below you will find all the dates of the financial publications for Ipsen Group for 2018.

Press releases

Strategy, appointments, major clinical, medical and regulatory advances, and partnerships: find all the latest Ipsen Group press releases listed by year.

Ipsen : 2018 financial objectives

Group sales growth

> 16.0%

Core operating margin

> 28.0%

Ipsen : H1 2017 financial results

Conference and roadshow presentations

Contact

Phone : +44 (0)1 753 627 721
Phone : +33 (0)1 58 33 53 31

Send an email